Metaiodobenzylguanidine (MIBG) scintigraphy and computed tomography (CT) in clinical practice. Primary and secondary evaluation for localization of phaeochromocytomas
- 6 March 2001
- journal article
- Published by Wiley in Journal of Internal Medicine
- Vol. 249 (3) , 247-251
- https://doi.org/10.1111/j.1365-2796.2001.00792.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Pheochromocytoma: Study of 50 CasesJournal of Urology, 1997
- Questionability of the benefits of routine laparotomy as the surgical approach for pheochromocytomas and abdominal paragangliomasSurgery, 1996
- Cardiac pheochromocytomaJournal of Internal Medicine, 1994
- Pheochromocytoma: Diagnosis by Scintigraphy Using Iodine 131 MetaiodobenzylguanidineSouthern Medical Journal, 1991
- Iodine 131-labeled metaiodobenzylguanidine scintigraphy and biochemical analyses in suspected pheochromocytomaArchives of internal medicine (1960), 1991
- Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphy.Radiology, 1987
- Radio-iodobenzylguanidine for the scintigraphic location and therapy of adrenergic tumorsSeminars in Nuclear Medicine, 1985
- Complementary roles of CT and 131I-MIBG scintigraphy in diagnosing pheochromocytomaAmerican Journal of Roentgenology, 1983
- Scintigraphic Localization of PheochromocytomaNew England Journal of Medicine, 1981